Yi Zhang
Corporate Officer/Principal presso The University of North Carolina at Charlotte
Posizioni attive di Yi Zhang
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| The University of North Carolina at Charlotte | Corporate Officer/Principal | - | - |
Storia della carriera di Yi Zhang
Precedenti posizioni note di Yi Zhang
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| EPIZYME, INC. | Fondatore | 01/11/2007 | - |
Formazione di Yi Zhang
| China Agricultural University | Graduate Degree |
| Florida State University | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 4 |
| Cina | 2 |
Posizioni
| Founder | 1 |
| Corporate Officer/Principal | 1 |
| Graduate Degree | 1 |
Settori
| Consumer Services | 4 |
| Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 1 |
|---|---|
Epizyme, Inc.
 Epizyme, Inc. BiotechnologyHealth Technology Epizyme, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the discovery, development, and commercialization of novel epigenetic medicines for cancer and other diseases. Its product pipeline is lead by, tazemetostat which targets Non-Hodgkin Lymphoma, molecularly defined solid tumors, non-small-cell lung carcinoma, molecularly targeted tumors, and ovarian cancer. The firm also develops pinometostat for genetically defined acute leukemia, and EZM8266 for sickle cell disease. The company was founded by Robert Horvitz and Zhang Yi on November 1, 2007 and is headquartered in Cambridge, MA. | Health Technology |
- Borsa valori
- Insiders
- Yi Zhang
- Esperienza
